Epileptic Syndromes: Clinical Trials

20 trials for Epileptic Syndromes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 3 withdrawn, 2 active not recruiting. 20 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 420Completed 6, Unknown 3, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2, Recruiting 2, Terminated 2

Follow Epileptic Syndromes: new trials by email Literature Review of Epileptic Syndromes trials Research Report on Epileptic Syndromes

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
Epidiolex 100 mg/mL Oral Solution - Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)
Phase 4Not yet recruitingElizabeth Donner252027-01-012026-09-11
A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS
Cannabidiol Oral Solution - Lennox-Gastaut Syndrome
Phase 4Not yet recruitingJazz Pharmaceuticals402026-11-182026-11-17
The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct) - Dravet Syndrome
Phase 4RecruitingThe University of Texas Health Science Center, Houston252026-04-272026-07-15
Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks vs. 14-day and no Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS)
Short-Duration Oral Prednisolone with Extended Tapering, Standard Oral Prednisolone Regimen with Tapering - Spasms, Infantile, Prednisolone
Phase 4Active not recruitingUniversity of Colombo1822025-01-012025-02-24
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
fenfluramine - Dravet Syndrome (DS), Children Under 2 Years
Phase 4RecruitingUniversity of Colorado, Denver52024-10-222026-05-15
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Cannabidiol - Lennox Gastaut Syndrome, Dravet Syndrome
Phase 4Active not recruitingJazz Pharmaceuticals1542021-07-072026-08-26
Fenfluramine and Cognition
Fenfluramine, Placebo - Cognitive Function
Phase 4CompletedUniversity of Oxford562021-04-122022-11-15
Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
GWP42003-P - Lennox-Gastaut Syndrome
Phase 4WithdrawnJazz Pharmaceuticals2020-10-012022-09-01
Hippocampal and Thalamic DBS for Bilateral Temporal Lobe Epilepsy
deep brain stimulation - Epilepsy, Temporal Lobe
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine802019-11-012019-11-15
Changing Agendas on Sleep, Treatment and Learning in Epilepsy
Carbamazepine, Levetiracetam, Parent based sleep (PBS) intervention - Rolandic Epilepsy
Phase 4TerminatedKing's College London52019-08-022020-11-02
Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes
conventional antiepileptic drugs, oral steroid - Benign Childhood Epilepsy With Centrotemporal Spikes
Phase 4UnknownAssiut University1002018-06-202020-08-13
Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines
SPG Block with 5% Lidocaine gel, Amitriptyline - Transformed Migraine, Chronic Daily Headache
Phase 4TerminatedRutgers, The State University of New Jersey102014-05-012026-06-23
Evaluation of Neuroinflammation in Children With Infantile Spasms
ACTH - Infantile Spasms
Phase 4CompletedWayne State University82013-03-012017-11-07
An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms
Vigabatrin - Infantile Spasms
Phase 4WithdrawnLundbeck LLC2012-06-012012-09-13
Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
melatonin, placebo - Lennox-Gastaut Syndrome
Phase 4WithdrawnInstitution de Lavigny2011-08-012022-07-14
Transcranial Direct Current Stimulation, Treatment of Childhood Drug-Resistant Lennox-Gastaut Syndrome, A Pilot Study
tDCS - Lennox-Gastaut Syndrome
Phase 4CompletedKhon Kaen University222010-08-012016-06-29
Donepezil Double Blind Trial for ECT Memory Disfunction
Donepezil - Schizophrenia, Schizoaffective Disorder
Phase 4UnknownBeerYaakov Mental Health Center402007-05-012009-01-27
Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy
escitalopram, placebo - Major Depression, Temporal Lobe Epilepsy
Phase 4CompletedConrad, Erich J., M.D.82006-11-012011-07-18
Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels
ECT treatment - Depressive Disorder, Major
Phase 4CompletedUniversity of Erlangen-Nürnberg Medical School102006-08-012020-12-14
Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
topamax - Epilepsy, Rolandic
Phase 4CompletedJanssen Korea, Ltd., Korea1142002-12-012011-02-01

Narrower conditions

Lennox Gastaut Syndrome (6)  ·  Epilepsies, Myoclonic (5)  ·  Epilepsy, Rolandic (5)  ·  Epilepsy, Temporal Lobe (3)  ·  Spasms, Infantile (3)  ·  Depressive Disorder, Major (2)  ·  Epilepsy (2)  ·  Seizures (2)  ·  Depression (1)  ·  Headache Disorders (1)  ·  Liver Cirrhosis (1)  ·  Migraine Disorders (1)  ·  Neuroinflammatory Diseases (1)  ·  Psychotic Disorders (1)  ·  Recurrence (1)

Broader conditions

Brain Diseases (20)  ·  Central Nervous System Diseases (20)  ·  Nervous System Diseases (20)  ·  Epilepsy (18)  ·  Epilepsies, Partial (8)  ·  Epilepsy, Generalized (8)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Genetic Diseases, Inborn (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Mental Disorders (4)  ·  Pathologic Processes (4)  ·  Depressive Disorder (2)  ·  Mood Disorders (2)  ·  Neurologic Manifestations (2)

Interventions

Cannabidiol (4)  ·  Fenfluramine (3)  ·  Carbamazepine (2)  ·  Levetiracetam (2)  ·  Adrenocorticotropic Hormone (1)  ·  Amitriptyline (1)  ·  Deep Brain Stimulation (1)  ·  Donepezil (1)  ·  Escitalopram (1)  ·  Melatonin (1)  ·  Methods (1)  ·  Oxcarbazepine (1)  ·  Prednisolone (1)  ·  Solutions (1)  ·  Steroids (1)

Sponsors

Jazz Pharmaceuticals (3)  ·  Assiut University (1)  ·  BeerYaakov Mental Health Center (1)  ·  Conrad, Erich J., M.D. (1)  ·  Elizabeth Donner (1)  ·  Institution de Lavigny (1)  ·  Janssen Korea, Ltd., Korea (1)  ·  Khon Kaen University (1)  ·  King's College London (1)  ·  Lundbeck LLC (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of Colombo (1)  ·  University of Colorado, Denver (1)

Countries

United States (7)  ·  United Kingdom (2)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  Germany (1)  ·  Israel (1)  ·  Sri Lanka (1)  ·  Switzerland (1)

Top investigators

Carukshi Arambepola, MSc, MD (1)  ·  Catherine J Harmer, DPhil (1)  ·  Elizabeth Donner, MD (1)  ·  Erich J Conrad, M.D (1)  ·  Gamal A Abdelal, MD (1)  ·  Giovanni B. Foletti, MD, MER (1)  ·  Jithangi Wanigasinghe, MD, MPhil (1)  ·  Kelly Knupp, MD (1)  ·  Nimesha Gamhewage, MD, DCH (1)  ·  Samden Lhatoo, MD, FRCP (1)  ·  Shalini Sri Ranganathan, MD, PhD (1)  ·  Shuang Wang, MD (1)  ·  Stefan Bleich, M.D. (1)

Results publications

PMID 20331461, PMID 25663221, PMID 27199889, PMID 39122687

NIH funding

2018 (1)